Here we have compiled our press releases for you. Editorial use of press releases and image material is free of charge. We would be pleased to receive a specimen copy and, for online use, the respective URL.
Lecanemab: digiDEM Bavaria calculates initial estimates for Germany
The new Alzheimer's drug Lecanemab has raised great hopes among people with dementia and their caregivers. Just recently, an expert panel of the European Medicines Agency (EMA) recommended the new active ingredient for treatment – with strict conditions. But which patient groups meet the criteria for
MAKS® Therapy Awarded MSD Health Prize
The MAKS® therapy was awarded an MSD Health Award 2024. The MAKS® program, which consists of several components, has been proven to help people with mild to moderate dementia maintain their cognitive abilities for as long as possible. The non-drug activation therapy helps to slow the progression of dementia and
Largest population screening for dementia in Germany
Is forgetfulness in old age normal? Or is it a sign of dementia? In conjunction with the 5th Bavarian Dementia Week, taking place from September 20th to September 29th, 2024, digiDEM Bayern is once again drawing attention to the increasingly important topic of early dementia detection. Around Dementia Week, the scientists at digiDEM Bayern have organized a total of 17 dementia screening days...
Preventing Cognitive Decline: The Social Network is Crucial
Neben Hörverlust, Bluthochdruck und Diabetes gehört soziale Isolation bei älteren Menschen zu den veränderbaren Risikofaktoren, die die Entwicklung einer Demenz begünstigen können. Ein interdisziplinäres Forschungsteam der Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) hat nun den Zusammenhang zwischen sozialer Isolation und kognitiven Beeinträchtigungen erforscht. Die Ergebnisse
